$136.4 M

ENZ Mkt cap, 14-Dec-2018

$21.3 M

Enzo Biochem Revenue Q1, 2019
Enzo Biochem Gross profit (Q1, 2019)7 M
Enzo Biochem Gross profit margin (Q1, 2019), %33%
Enzo Biochem Net income (Q1, 2019)-6 M
Enzo Biochem EBIT (Q1, 2019)-6 M
Enzo Biochem Cash, 31-Oct-201852.8 M

Enzo Biochem Revenue Breakdown

Embed Graph

Enzo Biochem revenue breakdown by business segment: 69.0% from Clinical Labs and 31.0% from Life Sciences

Enzo Biochem Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

93.7m95.9m97.6m102.8m107.8m104.7m

Revenue growth, %

2%2%5%

Cost of goods sold

46.0m

Gross profit

58.7m

Gross profit Margin, %

56%

R&D expense

3.1m3.4m3.5m2.9m3.2m

Operating expense total

106.1m98.8m3.5m2.9m3.2m

EBIT

(19.0m)(10.2m)(1.2m)47.0m(3.1m)(12.2m)

EBIT margin, %

(20%)(11%)(1%)46%(3%)(12%)

Interest expense

54.0k208.0k245.0k136.0k384.0k853.0k

Pre tax profit

(18.9m)(9.9m)(2.3m)46.5m(2.4m)(11.4m)

Income tax expense

(712.0k)(72.0k)7.0k(1.2m)(82.0k)1.1m

Net Income

(18.2m)(10.0m)(2.3m)45.3m(2.5m)(10.3m)

Quarterly

Enzo Biochem Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

9.0m17.5m18.1m67.8m64.2m60.0m

Accounts Receivable

12.3m12.5m6.7m6.7m

Inventories

8.8m8.7m7.4m7.0m7.0m7.3m

Current Assets

32.6m40.7m46.5m91.4m89.1m83.2m

PP&E

8.6m7.7m7.9m8.2m7.9m7.6m

Goodwill

7.5m7.5m7.5m7.5m7.5m7.5m

Total Assets

59.0m64.4m68.4m111.8m107.7m101.7m

Accounts Payable

8.2m8.8m10.4m9.5m

Current Liabilities

23.9m25.0m24.0m20.6m17.8m20.2m

Total Liabilities

27.5m25.8m22.3m18.8m20.5m

Additional Paid-in Capital

304.3m317.2m325.0m326.3m328.3m330.8m

Retained Earnings

(272.4m)(282.4m)(284.7m)(239.4m)(241.9m)(252.2m)

Total Equity

34.1m37.0m42.6m89.6m88.9m81.1m

Financial Leverage

1.7 x1.7 x1.6 x1.2 x1.2 x1.3 x

Enzo Biochem Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(18.2m)(10.0m)(2.3m)45.3m(2.5m)(10.3m)

Accounts Receivable

(2.6m)(3.2m)(2.0m)(4.8m)(3.2m)(1.8m)

Inventories

60.0k159.0k1.2m466.0k92.0k(413.0k)

Cash From Operating Activities

(10.0m)(1.7m)(3.7m)53.1m(205.0k)(2.7m)

Cash From Investing Activities

(971.0k)(833.0k)(1.8m)(1.5m)(1.7m)(1.9m)

Cash From Financing Activities

4.8m10.9m6.2m(1.9m)(1.7m)559.0k

Free Cash Flow

(11.0m)(2.5m)(5.5m)51.6m(2.0m)(4.6m)

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Net Income

(2.8m)(6.4m)(6.8m)(3.7m)(7.8m)(10.7m)4.4m11.3m9.2m(1.5m)(2.5m)(2.6m)(640.0k)(1.5m)(4.6m)(6.0m)

Accounts Receivable

(2.3m)(1.3m)(2.5m)(482.0k)(524.0k)(940.0k)(1.4m)(2.0m)(3.0m)(150.0k)(2.2m)(3.2m)(101.0k)(1.4m)(1.2m)312.0k

Inventories

(252.0k)(381.0k)(144.0k)107.0k306.0k597.0k(210.0k)(20.0k)447.0k(298.0k)(238.0k)(213.0k)(198.0k)(430.0k)(257.0k)(309.0k)

Cash From Operating Activities

(3.3m)(4.7m)(2.7m)(2.8m)(6.5m)(8.2m)13.2m20.1m17.0m(333.0k)(2.8m)(1.9m)2.6m835.0k(475.0k)(6.2m)

Cash From Investing Activities

(314.0k)(472.0k)(524.0k)(259.0k)(653.0k)(1.2m)(490.0k)(941.0k)(1.4m)(514.0k)(687.0k)(1.4m)(461.0k)(1.1m)(1.7m)(1.0m)

Cash From Financing Activities

2.0m3.7m8.9m2.2m5.1m6.4m(125.0k)(192.0k)(1.4m)303.0k(1.8m)(1.8m)557.0k520.0k532.0k(34.0k)

Free Cash Flow

(3.6m)(5.1m)(3.3m)(3.0m)(7.1m)(9.3m)12.6m19.1m15.6m(847.0k)(3.5m)(3.3m)2.1m(231.0k)(2.1m)(6.6m)

Enzo Biochem Ratios

USDY, 2018

Financial Leverage

1.2 x
Report incorrect company information

Enzo Biochem Operating Metrics

FY, 2016

Facilities

2

Patents Issued

314

Patents Pending

146
Report incorrect company information

Enzo Biochem Employee Rating

3.510 votes
Culture & Values
2.7
Work/Life Balance
2.9
Senior Management
2.7
Salary & Benefits
3.7
Career Opportunities
2.9
Source